CardiacPBPK: A tool for the prediction and visualization of time-concentration profiles of drugs in heart tissue
暂无分享,去创建一个
[1] Sebastian Polak,et al. Better prediction of the local concentration-effect relationship: the role of physiologically based pharmacokinetics and quantitative systems pharmacology and toxicology in the evolution of model-informed drug discovery and development. , 2019, Drug discovery today.
[2] Physiologically based pharmacokinetic-quantitative systems toxicology and safety (PBPK-QSTS) modeling approach applied to predict the variability of amitriptyline pharmacokinetics and cardiac safety in populations and in individuals , 2018, Journal of Pharmacokinetics and Pharmacodynamics.
[3] S. Polak,et al. Mechanistic Physiologically Based Pharmacokinetic (PBPK) Model of the Heart Accounting for Inter-Individual Variability: Development and Performance Verification. , 2017, Journal of pharmaceutical sciences.
[4] Stephanie Läer,et al. Physiologically Based Pharmacokinetic Modeling: Methodology, Applications, and Limitations with a Focus on Its Role in Pediatric Drug Development , 2011, Journal of biomedicine & biotechnology.
[5] Sebastian Polak,et al. Real Patient and its Virtual Twin: Application of Quantitative Systems Toxicology Modelling in the Cardiac Safety Assessment of Citalopram , 2017, The AAPS Journal.
[6] J. Brockmöller,et al. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. , 1997, American journal of human genetics.
[7] N. Patel,et al. Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin , 2018, The AAPS Journal.
[8] L. Bertilsson,et al. 10‐hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes , 1998, Clinical pharmacology and therapeutics.
[9] M. Wiese,et al. Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation , 2018, British journal of clinical pharmacology.
[10] Ivan Nestorov,et al. Whole Body Pharmacokinetic Models , 2003, Clinical pharmacokinetics.
[11] K Rowland-Yeo,et al. Basic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development , 2013, CPT: pharmacometrics & systems pharmacology.
[12] Kennon Heard,et al. A novel approach for estimating ingested dose associated with paracetamol overdose. , 2016, British journal of clinical pharmacology.
[13] F. Sjöqvist,et al. Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. , 1967, Life sciences.